Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (134)	12/5/2002 11:13:04 AM
From: arnold silver	Read Replies (1) \| Respond to of 3722

Too bad, I sold yesterday at $5.40. Thanks Arnie

To: Jibacoa who wrote (134)	12/5/2002 11:20:45 AM
From: Jibacoa	Respond to of 3722

TGEN Is up 18.37% on volume of 889,300 (more than 2x its daily average). It announced today the publication of data from its preclinical program in arthritis,which showed a significant suppression of chronic inflammatory arthritis in an animal model. Local delivery to one joint of its TNFR:Fc led to suppressed arthritis in other affected joints. The data appears in the December issue of Molecular Therapy. It also had announced yesterday that it is reacquiring full rights to it Cystic Fibrosis Program after receiving notification from CLL of its decision to terminate a previous collaborative agreement.<g> The shares need to close above its November 27 intra-day H 0f 0.67 bigcharts.marketwatch.com And are quite far from the November 4 H of 1.40 <g> bigcharts.marketwatch.com Bernard